Search Clinical Trials
583,695 trials
ID
Status
Phase
Title
Sponsor
NCT07574606
Assessment of Soft Tissue Thickness Over Zygomatic Implants in Atrophied Maxilla Covered With Buccal Fat Pad vs. Palatal Pedicle FlapFuture University in EgyptRecruitingNot Applicable
NCT07574606Recruiting
Not Applicable
Assessment of Soft Tissue Thickness Over Zygomatic Implants in Atrophied Maxilla...Future University in Egyp...
NCT07576036
International Multi-center Retrospective Study of Patients With Serum Sodium ≤110 mmol/L to Determine the Relationship Between Osmotic Demyelination Syndrome (ODS) and Rapid Correction of HyponatremiaRochester General HospitalEnrolling By Invitation
NCT07576036Enrolling By Invitation
—
International Multi-center Retrospective Study of Patients With Serum Sodium ≤11...Rochester General Hospita...
NCT07575061
A 15-year Cohort Study on Risk Factors of Mortality in Patients With Intestinal TuberculosisBeijing Chest Hospital, Capital Medical UniversityRecruiting
NCT07575061Recruiting
—
A 15-year Cohort Study on Risk Factors of Mortality in Patients With Intestinal...Beijing Chest Hospital, C...
NCT07575100
MAITLAND MOBILIZATION VERSUS THERAPEUTIC ULTRASOUND ON TRISMUS FOLLOWING THIRD MOLAR SURGERYCairo UniversityCompletedNot Applicable
NCT07575100Completed
Not Applicable
MAITLAND MOBILIZATION VERSUS THERAPEUTIC ULTRASOUND ON TRISMUS FOLLOWING THIRD M...Cairo University
NCT07575906
A Study to Learn How a Single Dose of the Study Medicine Called PF-08057418 is Tolerated in the Body of Healthy Adults.PfizerNot Yet RecruitingPhase 1
NCT07575906Not Yet Recruiting
Phase 1
A Study to Learn How a Single Dose of the Study Medicine Called PF-08057418 is T...Pfizer
NCT07575880
Screening for Obstructive Respiratory Disorders in the General Population During the "Mai Poumon 2026" Prevention Campaign: Prevalence and Impact on the Care PathwayCentre Hospitalier de la côte BasqueNot Yet Recruiting
NCT07575880Not Yet Recruiting
—
Screening for Obstructive Respiratory Disorders in the General Population During...Centre Hospitalier de la...
NCT07574853
Study on Silk Fibroin-Reinforced Collagen-Based Composite Membrane for Periodontal Bone Tissue RegenerationThe First Affiliated Hospital of Xinxiang Medical CollegeNot Yet RecruitingNot Applicable
NCT07574853Not Yet Recruiting
Not Applicable
Study on Silk Fibroin-Reinforced Collagen-Based Composite Membrane for Periodont...The First Affiliated Hosp...
NCT07574827
Candida Albicans in Syrian Patients With PeriodontitisAl-Hawash Private UniversityRecruiting
NCT07574827Recruiting
—
Candida Albicans in Syrian Patients With PeriodontitisAl-Hawash Private Univers...
NCT07574450
Taiwan ED Airway Quality Surveillance Registry (TEAR)Chang Gung Memorial HospitalNot Yet Recruiting
NCT07574450Not Yet Recruiting
—
Taiwan ED Airway Quality Surveillance Registry (TEAR)Chang Gung Memorial Hospi...
NCT07576413
Effects of Standing Desks and Intermittent Walking on Cognitive FatigueClarkson UniversityCompletedNot Applicable
NCT07576413Completed
Not Applicable
Effects of Standing Desks and Intermittent Walking on Cognitive FatigueClarkson University
NCT07575360
PT-GBD to EUS-GBD Conversion Versus Standard Management in High-Risk Acute Cholecystitis PatientsUniversity of BolognaCompleted
NCT07575360Completed
—
PT-GBD to EUS-GBD Conversion Versus Standard Management in High-Risk Acute Chole...University of Bologna
NCT07576933
Effects of Two Intervention Programs on Physical Fitness and Quality of Life Among People With Intellectual DisabilitiesUniversidad Católica San Antonio de MurciaEnrolling By InvitationNot Applicable
NCT07576933Enrolling By Invitation
Not Applicable
Effects of Two Intervention Programs on Physical Fitness and Quality of Life Amo...Universidad Católica San...
NCT07576257
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili-cate in Heart Failure -Extension (OPRA-HF Extension)Sahlgrenska University HospitalNot Yet RecruitingPhase 2
NCT07576257Not Yet Recruiting
Phase 2
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili...Sahlgrenska University Ho...
NCT07575412
SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDSThe First Affiliated Hospital of Soochow UniversityNot Yet RecruitingPhase 2
NCT07575412Not Yet Recruiting
Phase 2
SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDSThe First Affiliated Hosp...
NCT07575724
Comparison of the Effects of Needle Biopsy Tract Resection and Non-resection on Recurrence Rate in Patients With Primary Extremity SarcomaSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityNot Yet RecruitingPhase 2
NCT07575724Not Yet Recruiting
Phase 2
Comparison of the Effects of Needle Biopsy Tract Resection and Non-resection on...Second Affiliated Hospita...
NCT07576842
Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIVBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576842Not Yet Recruiting
Not Applicable
Testing the Feasibility of Different HPV Screening and Care Strategies for Women...Beth Israel Deaconess Med...
NCT07576660
Dexamethasone Treatment for Sepsis-associated Acute Respiratory Distress Syndrome: a Multicenter, Randomised, Double-blinded, Controlled TrialSoutheast University, ChinaNot Yet RecruitingPhase 3
NCT07576660Not Yet Recruiting
Phase 3
Dexamethasone Treatment for Sepsis-associated Acute Respiratory Distress Syndrom...Southeast University, Chi...
NCT07575581
Psychometric Evaluation of the EVARUCI Scale in Turkish Intensive Care UnitsIstanbul UniversityCompleted
NCT07575581Completed
—
Psychometric Evaluation of the EVARUCI Scale in Turkish Intensive Care UnitsIstanbul University
NCT07575243
Thyroidectomy-specific Enhanced Recovery After Surgery (ERAS) ProtocolAssiut UniversityCompleted
NCT07575243Completed
—
Thyroidectomy-specific Enhanced Recovery After Surgery (ERAS) ProtocolAssiut University
Result Breakdown
Not yet recruiting9 (45%)
Completed5 (25%)
Recruiting4 (20%)
Enrolling by invitation2 (10%)
Not Specified9 (45%)
not_applicable6 (30%)
Phase 23 (15%)
Phase 11 (5%)
Phase 31 (5%)